We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Carecapital | CARE | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.815 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.815 | 0.815 |
| Top Posts |
|---|
Posted at 10/8/2012 15:12 by fenseal3 Every share i'm in that issues shares always end up being cheaper than the mid price....then the share drops and peeps moan and scowl behind their laptops..we get a company that issues shares above mid and peeps say nothing, not only that we have sells @ 0.82p...i for one congratulate the BOD at CARE for a fine job, peeps need to get a life and decide why they became investors or are they just gamblers, rant over with..this will be 2p soon!! |
Posted at 28/6/2012 07:25 by mike_f Appointment of Non-executive DirectorCareCapital (AIM: CARE) is pleased to announce the appointment of Trevor Brown as a Non-executive Director with immediate effect. Trevor Brown (66) has been a strategic investor in real estate and equities for more than 30 years. Mr Brown is a director of Free Association Books Limited in London. He has a beneficial interest as at the date of this announcement in 15,334,001 ordinary shares of CareCapital, representing 9.38% of the Company's current issued share capital. There is no further information required to be disclosed in relation to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies. Commenting on the appointment, Dr Mike Sinclair, CareCapital's CEO, said, "I am pleased that Trevor has agreed to join the Board as a Non-executive Director. He is, and has been, a supporter of our plans to refocus CareCapital on the provision of advanced cancer treatment services. His experience and track record will greatly benefit our Board, our management team and our shareholders. I welcome him to CareCapital." |
Posted at 21/6/2012 09:29 by fenseal3 This is the time to buy...offer still under 1p and investors nibbling, might see blue today, fantastic long term punt!!! |
Posted at 11/6/2012 14:34 by fenseal3 Big time investors buying, small time investors selling.....simples! |
Posted at 08/6/2012 13:38 by fenseal3 How many times do we see shares where their own investors never buy in...we have two keen investors that have an appetite for CARE, you always find the quiet ones are the ones that surprise us all, i have also topped up today and long term look forward to my rewards GLA!!!! |
Posted at 08/6/2012 13:17 by 345654 Hey Howard and others !I remember this chap from my Market Eye days, i got roped in a right dog called Transacsys TYS around the dot come boom, when the stock was dead and buried this guy came along and from memory bought a huge stake at around 2-3p and i thought why is he buying this pile and it was not not long later there was a bid at 7p Check out this link, it is 10 years old but it is him, makes this interesting. |
Posted at 15/5/2012 14:04 by fenseal3 nible, nible, nible, bid up peeps buying....not all bad, we know Peter keeps buying, and he knows more than us small time investors!!!!!!!when this turns watch out!!!! |
Posted at 28/3/2012 08:30 by fenseal3 Seems to have the same pattern as OXS peeps happy to take a small profit, other peeps happy to pay 2p or over...new investors will mean a new level each day....GLA!!!!! |
Posted at 28/3/2012 07:08 by sharewinner2 CARECAPITAL GROUP PLC("CareCapital", "the Group" or "the Company") Restructuring, Proposed Change of Name Changes to Senior Management and Board Responsibilities Care Capital announces a restructuring to reflect its strategy to reposition the Group primarily as an investor in, and provider of, advanced cancer treatments. Current investments in medical centre development projects are to be transferred to the Group's wholly owned subsidiary - The Healthcare Property Company Limited - which will continue to progress existing schemes and expand through securing new medical centre projects in the UK. This company will also provide property related support services to the wider Group. The Company also announces that it will be seeking shareholder authority at the earliest opportunity to change its name to Advanced Oncotherapy plc. Changes to Board and senior management responsibilities, all with immediate effect, to reflect the shift in strategic focus are set out below: · Lord Evans of Watford, currently the Senior Independent Non-executive Director, has become Non-executive Chairman · Dr Michael Sinclair has stepped down as Executive Chairman to become Group Chief Executive with a focus on developing and growing the Group's interests in advanced cancer treatments · Paul Stacey, currently Chief Executive, has become Managing Director of The Healthcare Property Company Limited · Dr Sinclair and Mr Stacey will continue as Directors of the Company. Further appointments to the Board are expected to be announced in due course. Commenting on the restructuring, proposed name change and new team responsibilities, Mike Sinclair, Group Chief Executive, said, "The new direction for the Company is today recognised in the restructuring of our businesses and management responsibilities as well as the proposed change of name and sector re-classification. I very much hope that this sharper focus will enable the management team to continue to restore and create value for shareholders through our historic real estate activities and our newer, higher potential cancer treatment interests." |
Posted at 31/1/2012 16:33 by crosswire Speaking of share prices, CareCapital (LON:CARE) was the top performer in London market in morning trade.The real estate investors with a focus on healthcare saw its share price nearly triple in early deals after saying that its 29.75 percent stake in Advanced Proton Solutions has the potential to "be of significant value". According to the group, as a result of its involvement in APS, it has been approached by a number of providers of cancer treatments and said its operations in this field could form the basis of a new healthcare division within the group. In November last year, the group sold its German portfolio for 27.35 million, allowing it to investment in its UK healthcare development pipeline. The group currently has developments worth a total £21.8 million, of which £14.6 million has been forward sold to investors. Today, the group said it expects to completed these developments within the next two years. In early afternoon, shares in the company traded at 3.88 pence, up 158 percent from yesterday's close. CareCapital now has a market cap of nearly £3 million. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
